Non-alcoholic fatty liver disease

  • HOME
  • TOPICS
  • Non-alcoholic fatty liver disease
Original Article
1656
Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
Clin Mol Hepatol. 2022;28(2):196-206.   Published online January 13, 2022
View: 2308   Download: 139  Citation: 1
1648
Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
Wen-Yue Liu, Xiaofang Zhang, Gang Li, Liang-Jie Tang, Pei-Wu Zhu, Rafael S. Rios, Kenneth I. Zheng, Hong-Lei Ma, Xiao-Dong Wang, Qiuwei Pan, Robert J. de Knegt, Luca Valenti, Mohsen Ghanbari, Ming-Hua Zheng
Clin Mol Hepatol. 2022;28(2):183-195.   Published online November 28, 2021
View: 2334   Download: 168  Citation: 1
1639
Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park
Clin Mol Hepatol. 2022;28(1):105-116.   Published online October 15, 2021
View: 3307   Download: 146  Citation: 1
1633
Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes
Hydar El Jamaly, Guy D Eslick, Martin Weltman
Clin Mol Hepatol. 2022;28(1):52-66.   Published online September 17, 2021
View: 3675   Download: 163  Citations: 3
Editorial
Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
Ja-Young Kwon
Clin Mol Hepatol. 2022;28(1):50-51.   Published online November 22, 2021
View: 1857   Download: 71
Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
Seung Mi Lee, Won Kim
Clin Mol Hepatol. 2022;28(1):47-49.   Published online November 30, 2021
View: 1954   Download: 76  Citation: 1
Review
1616
Recent advances in nonalcoholic fatty liver disease metabolomics
Hwi Young Kim
Clin Mol Hepatol. 2021;27(4):553-559.   Published online June 8, 2021
View: 5640   Download: 327  Citations: 7
Original Article
1605
Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
Yi-Wen Ting, Amanda Shen-Yee Kong, Shamsul Mohd Zain, Wah-Kheong Chan, Hwa-Li Tan, Zahurin Mohamed, Yuh-Fen Pung, Rosmawati Mohamed
Clin Mol Hepatol. 2021;27(3):486-498.   Published online February 23, 2021
View: 2699   Download: 205  Citations: 10
Editorial
An analysis of polygenic risk scores for non-alcoholic fatty liver disease
Dae Won Jun
Clin Mol Hepatol. 2021;27(3):446-447.   Published online May 21, 2021
View: 2429   Download: 122
Guideline
1619
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee, Yong Kyun Cho
Clin Mol Hepatol. 2021;27(3):363-401.   Published online June 22, 2021
View: 10609   Download: 1,002  Citations: 50
Original Article
1597
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding
Clin Mol Hepatol. 2021;27(2):329-345.   Published online January 20, 2021
View: 3600   Download: 184  Citations: 6
Review
1612
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
Clin Mol Hepatol. 2021;27(2):257-269.   Published online March 22, 2021
View: 4614   Download: 355  Citations: 30
1585
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2021;27(2):221-235.   Published online December 3, 2020
View: 4458   Download: 313  Citations: 16
Original Article
1574
Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk
Clin Mol Hepatol. 2021;27(1):110-124.   Published online December 3, 2020
View: 5482   Download: 353  Citations: 29
Editorial
1588
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clin Mol Hepatol. 2021;27(1):83-86.   Published online December 3, 2020
View: 2873   Download: 127
Review
1563
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clin Mol Hepatol. 2021;27(1):44-57.   Published online November 19, 2020
View: 8753   Download: 298  Citations: 12
1568
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison, Christopher D. Byrne
Clin Mol Hepatol. 2021;27(1):22-43.   Published online December 10, 2020
View: 5760   Download: 365  Citations: 22
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
Kenichi Ikejima, Kazuyoshi Kon, Shunhei Yamashina
Clin Mol Hepatol. 2020;26(4):728-735.   Published online October 1, 2020
View: 3591   Download: 142  Citations: 17
Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
Sen Han, Ting Zhang, Praveen Kusumanchi, Nazmul Huda, Yanchao Jiang, Zhihong Yang, Suthat Liangpunsakul
Clin Mol Hepatol. 2020;26(4):705-714.   Published online October 1, 2020
View: 2564   Download: 68  Citations: 3
Letter to the Editor
Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
Dimitrios Patoulias, Michael Doumas
Clin Mol Hepatol. 2020;26(4):582-583.   Published online September 25, 2020
View: 2098   Download: 63
Review
1531
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2020;26(4):461-475.   Published online September 10, 2020
View: 5309   Download: 232  Citations: 20
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clin Mol Hepatol. 2020;26(4):430-443.   Published online August 14, 2020
View: 5960   Download: 371  Citations: 18
1526
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray
Clin Mol Hepatol. 2020;26(4):383-400.   Published online July 17, 2020
View: 6541   Download: 448  Citations: 26
Letter to the Editor
Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
Jung Hwan Yu
Clin Mol Hepatol. 2020;26(2):240-241.   Published online March 23, 2020
View: 2626   Download: 40
Original Article
Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky
Clin Mol Hepatol. 2020;26(2):216-226.   Published online December 5, 2019
View: 4402   Download: 128  Citations: 10
Editorial
Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?
Soung Won Jeong
Clin Mol Hepatol. 2020;26(2):185-186.   Published online March 23, 2020
View: 2812   Download: 73
Review
1486
Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2020;26(2):128-141.   Published online November 8, 2019
View: 9894   Download: 494  Citations: 38
Letter to the Editor
Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steatohepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists
Prasit Phowthongkum, Kanya Suphapeetiporn, Vorasuk Shotelersuk
Clin Mol Hepatol. 2019;25(4):412-416.   Published online June 24, 2019
View: 3665   Download: 111  Citation: 1
Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Michael Doumas
Clin Mol Hepatol. 2019;25(3):331-332.   Published online May 30, 2019
View: 2912   Download: 54

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 806
TOTAL : 1046295
Close layer